Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00103831 · ClinicalTrials.gov registry record · Phase 1
Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00103831: Completed Phase 1 study, sponsored by Bristol-Myers Squibb.
NCT00103831 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00103831, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
A phase I-II dose ranging study of BMS-275183 (oral taxane) in combination with pemetrexed (Alimta) in patients with recurrent Non-Small Cell Lung Cancer (NSCLC). The safety and efficacy of this combination will be studied.
Interventions
- DRUG Oral Taxane
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00103831 record still lists
NCT00103831 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Oral Taxane is the first listed.
NCT00103831 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00103831 about?
NCT00103831 is a clinical study titled "Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer". A phase I-II dose ranging study of BMS-275183 (oral taxane) in combination with pemetrexed (Alimta) in patients with recurrent Non-Small Cell Lung Cancer (NSCLC). The safety and efficacy of this combination will be studied.
What is the current status of trial NCT00103831?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00103831?
The interventions under investigation include: Oral Taxane (DRUG).
Who is sponsoring clinical trial NCT00103831?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.